Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Unknown
Checked: April 17, 2026 at 5:01 AM UTC
| NCT Number | NCT06056323 |
| Recruiting Status | Unknown |
| Condition | Advanced Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 71 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Shanghai Huaota Biopharmaceutical Co., Ltd. |
| Last Updated on CT.gov | October 23, 2023 (Oct 23, 2023) |
As of April 17, 2026: Clinical trial NCT06056323 is currently unknown participants. This clinical trial study for advanced solid tumors is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Shanghai Huaota Biopharmaceutical Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06056323 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06056323 was last updated Oct 23, 2023 (October 23, 2023). HelloStudys verifies this status automatically.